on SAFE (isin : FR0013467123)
SAFE obtains a favorable opinion for its recovery plan
At the hearing on October 18, 2024 at the Paris Commercial Court, the Safe group, specializing in medical devices for spinal surgery, received a favorable opinion regarding its recovery plans. This positive decision, which concerns Safe SA as well as its subsidiaries Safe Orthopaedics and Safe Medical, is crucial for the future of the group. The decision will be rendered from November 5. In the meantime, Safe undertakes to keep the market informed of developments in the procedure.
Safe Group, with approximately 100 employees, is recognized for its innovation in ready-to-use technologies, including SteriSpineTM kits, used in minimally invasive surgery. The group has a presence in France, the United Kingdom, Germany and the United States.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SAFE news